In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK to report on transfusion-related vCJD (variant Creutzfeldt-Jakob disease) risk assessment:

This article was originally published in Clinica

Executive Summary

The UK is preparing to announce the results of an exercise to assess the risk of transmission of variant Creutzfeldt-Jakob disease (vCJD) via blood transfusion. It follows the confirmation in July of a second case of suspected infection. Precautionary measures were adopted in December 2003, following the first reported case. The problem surrounds the processing of UK plasma pooled from "many thousands" of UK donors. The results of the risk assessment exercise and any further precautionary measures will be announced at the end of a patient-notification exercise currently underway. Switzerland has announced that it is following the UK's lead in restricting the number of people who can be blood donors.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059635

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel